No intervention
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Optic Neuropathy, Ischemic
Conditions
Optic Neuropathy, Ischemic
Trial Timeline
Nov 1, 2008 → Oct 1, 2012
NCT ID
NCT00759174About No intervention
No intervention is a pre-clinical stage product being developed by Pfizer for Optic Neuropathy, Ischemic. The current trial status is completed. This product is registered under clinical trial identifier NCT00759174. Target conditions include Optic Neuropathy, Ischemic.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00759174 | Pre-clinical | Completed |
Competing Products
20 competing products in Optic Neuropathy, Ischemic